Preserving the delicate balance between NETs generation and clearance is therefore fundamental to maintaining immune homeostasis and preventing disease
These treatments may be appropriate if: You have a BMI of 30 or higher (obesity), or 27 or higher with weight-related health conditions You have struggled to lose weight despite consistent diet and exercise efforts You have insulin resistance, prediabetes, or metabolic syndrome You carry excess visceral fat that increases cardiovascular and metabolic risk You want medical support for long-term, sustainable weight management You have experienced weight regain after previous dieting attempts You are committed to combining treatment with nutrition, movement, and lifestyle changes Who Should Avoid or Use Caution Individuals with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome (contraindication for GLP-1 agonists) Those with a history of pancreatitis Pregnant or breastfeeding women Individuals with active gallbladder disease Those with severe gastrointestinal conditions Anyone with pituitary disorders (for GH-releasing peptides) What to Expect During Treatment First Month Gradual dose titration to minimize side effects Early appetite reduction with GLP-1 agonists Possible mild nausea that typically improves with time Initial weight loss of 2 to 5 pounds (much of this may be water weight) Months 2-3 Steady, consistent weight loss of 1 to 2 pounds per week Significant reduction in hunger and cravings Improved energy levels and sleep quality Early body composition changes becoming visible Months 3-6 Continued weight loss with improving body composition Clothes fitting differently, visible physical changes Metabolic markers (blood sugar, cholesterol, blood pressure) improving Workout performance and recovery often enhanced Months 6-12 Approaching maximum weight loss potential for the given peptide Significant improvements in metabolic health markers Sustained appetite regulation Long-term lifestyle habits becoming established Are Weight Loss Peptides Safe
Nutritional Deficiencies The mechanism that makes GLP-1 medications effective, slowing digestion and reducing food intake, can also lead to significant nutritional gaps: Many patients consume fewer calories, making it difficult to obtain adequate nutrients Altered digestive processes may reduce the efficiency of nutrient absorption Key nutrients at risk include calcium, vitamin D, B vitamins, iron, and protein 4
Another may include medication, refill review, and shipping
